Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Adcock Ingram Ltd | 3 |
| 2 | Royal Melbourne Institute of Technology | 3 |
| 3 | Melbourne Institute of Technology | 2 |
| 4 | Academia Sinica | 1 |
| 5 | Access to Advanced Health Institute | 1 |
| 6 | Albert Einstein College of Medicine | 1 |
| 7 | Bekaert NV SA | 1 |
| 8 | Colorado State University Research Foundation | 1 |
| 9 | Consejo Superior de Investigaciones Científicas | 1 |
| 10 | Ford Motor Co | 1 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | G01N | Investigating / analysing materials | 47 |
| 2 | A61K | Medicinal preparations | 46 |
| 3 | A61P | Therapeutic activity (drug indications) | 30 |
| 4 | C07H | Sugars and derivatives | 30 |
| 5 | C12N | Microorganisms, enzymes | 18 |
| 6 | C07K | Peptides | 14 |
| 7 | C07C | Acyclic and carbocyclic compounds | 12 |
| 8 | C09K | Materials for misc. applications | 12 |
| 9 | Y02A | Climate change adaptation | 10 |
| 10 | C07D | Heterocyclic compounds | 9 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| PSEUDO-AMIDE CORD FACTORS IN THE SERODIAGNOSIS OF TUBERCULOSIS IN ANIMALS | 1995 | INFLAZYME PHARMACEUTICALS LTD. | 0 |
| Mirror amide cord factors and mirror thioester cord factors for diagnosis of tuberculosis | 1995 | INFLAZYME PHARMACEUTICALS, INC. | 0 |
| Mirror amide cord factors and mirror thioester cord factors for diagnosis of tuberculosis | 1994 | INFLAZYME PHARMACEUTICALS CANADA INC. | 0 |
| MIRROR AMIDE CORD FACTORS AND MIRROR THIOESTHER CORD FACTORS FOR DIAGNOSIS OF TUBERCULOSIS | 1994 | INFLAZYME PHARMACEUTICALS INC. | 0 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Mycobacterium research and diagnosis | 3 |
| 2 | Tuberculosis Research and Epidemiology | 3 |
| 3 | Cutaneous lymphoproliferative disorders research | 1 |
| 4 | Cybercrime and Law Enforcement Studies | 1 |
| 5 | Design Education and Practice | 1 |
| 6 | Endometriosis Research and Treatment | 1 |
| 7 | Helicobacter pylori-related gastroenterology studies | 1 |
| 8 | Immune Cell Function and Interaction | 1 |
| 9 | Immune Response and Inflammation | 1 |
| 10 | Infant Nutrition and Health | 1 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Ikuya Yano | Osaka City University | 35 |
| 2 | E. Lederer | Institut de Chimie des Substances Naturelles | 17 |
| 3 | E Yarkoni | National Cancer Institute | 13 |
| 4 | Jeffrey K. Actor | The University of Texas Health Science Center at Houston | 13 |
| 5 | Robert L. Hunter | The University of Texas Health Science Center at Houston | 13 |
| 6 | Ichiro Azuma | Hokkaido University | 11 |
| 7 | G. Lemaire | Université Paris-Sud | 10 |
| 8 | Célio Lopes Silva | Universidade de São Paulo | 9 |
| 9 | A. Bekierkunst | Hebrew University of Jerusalem | 8 |
| 10 | Nagatoshi Fujiwara | Osaka City University | 8 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle | 2009 | 783 | Tuberculosis Research and Epidemiology |
| Role of the Major Antigen of <i>Mycobacterium tuberculosis</i> in Cell Wall Biogenesis | 1997 | 734 | Tuberculosis Research and Epidemiology |
| Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism | 2010 | 508 | Tuberculosis Research and Epidemiology |
| SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis | 2012 | 507 | Tuberculosis Research and Epidemiology |
| Cutting Edge: Mincle Is Essential for Recognition and Adjuvanticity of the Mycobacterial Cord Factor and its Synthetic Analog Trehalose-Dibehenate | 2010 | 491 | T-cell and B-cell Immunology |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of Cord Factor?
What are the leading research topics and applications for Cord Factor?
Which institutions and organizations are most active in Cord Factor patent development?
Who are the most prolific researchers in Cord Factor studies?
What is the scope of patent and publication activity on Cord Factor?